Buspirone Treatment of Anxiety in Williams Syndrome
Status:
Recruiting
Trial end date:
2025-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to do a preliminary assessment of whether buspirone is
effective, safe, and tolerable in the treatment of anxiety in children, adolescents, and
adults with Williams syndrome.